Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira A Jacobs

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2016
Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell LymphomaMorton Coleman, Philip E Lammers, Fabio Ciceri, et al.
The American Surgeon|April 22, 2004
Clear cell sarcoma: an institutional reviewIra A Jacobs, C K Chang, Grace Guzman, et al.
Archives of Pathology & Laboratory Medicine|March 26, 2003
Metastatic infiltrating syringomatous adenoma of the breastC K Chang, Ira A Jacobs, Gabriel Calilao, et al.
The American Surgeon|November 25, 2003
Thick melanoma in the elderlyC K Chang, Ira A Jacobs, Elena Theodosiou, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 7, 2003
High isotope counts and sentinel node positivity in patients with melanomaIra A Jacobs, C K Chang, Tapas K DasGupta, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 15, 2003
Melanoma in the elderly patientC K Chang, Ira A Jacobs, Vida M Vizgirda, et al.
Annals of Surgical Oncology|June 10, 2003
Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanomaIra A Jacobs, C K Chang, Tapas K DasGupta, et al.
Drug Design, Development and Therapy|July 8, 2015
Development of biosimilars in an era of oncologic drug shortagesEdward Li, Janakiraman Subramanian, Scott Anderson, et al.
Future Oncology (London, England)|August 10, 2019
Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologicsKenneth C Anderson, Ola Landgren, Rebecca C Arend, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 22, 2016
Assessing the Immunogenicity of BiopharmaceuticalsCarlos Pineda, Gilberto Castañeda Hernández, Ira A Jacobs, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2016
Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell LymphomaMorton Coleman, Philip E Lammers, Fabio Ciceri, et al.
The American Surgeon|April 22, 2004
Clear cell sarcoma: an institutional reviewIra A Jacobs, C K Chang, Grace Guzman, et al.
Archives of Pathology & Laboratory Medicine|March 26, 2003
Metastatic infiltrating syringomatous adenoma of the breastC K Chang, Ira A Jacobs, Gabriel Calilao, et al.
The American Surgeon|November 25, 2003
Thick melanoma in the elderlyC K Chang, Ira A Jacobs, Elena Theodosiou, et al.
Archives of Surgery (Chicago, Ill. : 1960)|January 7, 2003
High isotope counts and sentinel node positivity in patients with melanomaIra A Jacobs, C K Chang, Tapas K DasGupta, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 15, 2003
Melanoma in the elderly patientC K Chang, Ira A Jacobs, Vida M Vizgirda, et al.
Annals of Surgical Oncology|June 10, 2003
Role of sentinel lymph node biopsy in patients with thin (<1 mm) primary melanomaIra A Jacobs, C K Chang, Tapas K DasGupta, et al.
Drug Design, Development and Therapy|July 8, 2015
Development of biosimilars in an era of oncologic drug shortagesEdward Li, Janakiraman Subramanian, Scott Anderson, et al.
Future Oncology (London, England)|August 10, 2019
Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologicsKenneth C Anderson, Ola Landgren, Rebecca C Arend, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 22, 2016
Assessing the Immunogenicity of BiopharmaceuticalsCarlos Pineda, Gilberto Castañeda Hernández, Ira A Jacobs, et al.
Pageof 4